Harm Reduction and Hepatitis C

September 15, 2020
Registration


There is no cost to attend. Sessions are the third Tuesday of the month. 

The HCV ECHO is a tele-mentoring program that uses videoconferencing technology (Zoom) to combine MAT didactic presentations with interactive and practical HCV case presentations from participants.

To register, email ECHO@iowapca.org the following information: Name, title, credentials, organization name, and email address.
 

Target Audience

Providers and clinical staff who are interested in providing treatment and care to individuals diagnosed with Hepatitis C (providers, nursing, behavioral health, linkage navigators, front desk/scheduling, admin, etc.).

Purpose

This interactive web-based program provides community-focused primary care clinicians an opportunity to become experts in the delivery of Hepatitis C care through a mentoring-based initiative. Project ECHO, developed by Dr. Sanjeev Aurora at the University of New Mexico (UNM) in 2003, provides a framework for sharing expertise across the state and as a result will help patients achieve a viral cure and avoid the downstream sequela associated with HCV without leaving the providers they trust and the communities where they live and work. Interested providers do not have to have any prior experience in treating Hepatitis C to participate in HCV ECHO.

The mission is to help centers and primary care providers manage HCV patients at their primary care center to alleviate barriers to care for un/underinsured patients by increasing the providers’ abilities to treat their patients at their primary care health center.

Professional Practice Gap

Iowa Medicaid requires medication treatment for HCV be prescribed by or in consult with a specialist. This creates a barrier to care for un/underinsured patients and a gap in care for patients and primary care providers that do not have access to specialists in their communities where specialists (infectious disease/hepatologists) are scarce or will only see a limited number of Medicaid patients.  

The HCV ECHO will allow primary care providers to meet the prescribing requirement for Medicaid patients and to consult with specialists for all of their patients with HCV to allow the patients to be treated by their PCP at their local health center thus decreasing barriers to care and increasing positive health outcomes. The ECHO model allows for PCPs to increase their knowledge and skill set regarding Hepatitis C treatment and care through the didactic sessions and mentoring from specialists.  

Learning Objectives

  • Provide a brief background of national and state substance use the disease of addiction.
  • Discuss the relationship between injection drug use and hepatitis C. 
  • Introduce principles and examples of harm reduction.
  • Discuss harm reduction in the context of people who inject drugs. 
  • Discuss barriers to hepatitis C care for people who use drugs. 
  • Outline harm reduction principles applicable to working with people who use drugs in a healthcare setting.
  • Identify opportunities to use harm reduction principles in treating HCV among people who use drugs.
  • Highlight collaborative projects at IDPH to address drug use and infectious diseases.

Agenda

11:45 am

Didactic Sessions

Topics may include: 

  • Hepatitis C 101
  • HCV Treatment medications and access to treatment
  • Treatment Considerations for People Living with HCV (re-infection; Genotyping; people who use substances; necessary lab work; etc.)
  • Health Economics 101: Standard v. Enhanced Screening and Treatment
  • Drug User Health and Person-Centered Language
  • Treating Patients with Substance Use Disorders and HCV
  • Co-Infections: HIV and HCV
  • Populations Disproportionately Impacted by HCV and/or HIV (LGBTQ+; Persons experiencing human trafficking and Intimate Partner Violence; racial and ethnic groups)
  • HCV Screening among pregnant women
12:30 pm

Case Presentations

You do not need to present a case during every session in order to participate in the HCV clinic. However, the submission of cases for presentation and discussion is a key component in the Project ECHO model and critically important for knowledge building and sharing, and it is therefore required that each provider present at minimum three cases per year. We welcome cases that involve common clinical scenarios related to HCV diagnosis and care as well as difficult, complex, or challenging presentations and patient management scenarios.

    Course summary
    Available credit: 
    • 1.50 AMA PRA Category 1 Credits
    • 1.50 AOA Category 2­A
    • 1.50 CE Contact Hour(s)
    • 1.50 IBON
    Course opens: 
    09/15/2020
    Course expires: 
    09/15/2020
    Event starts: 
    09/15/2020 - 11:45am
    Event ends: 
    09/15/2020 - 1:15pm
    Cost:
    $0.00
    Rating: 
    0

    Speaker

    Liz Sweet
    Systems Integration Coordinator at IDPH Division of Behavioral Health Contracting

    HCV ECHO HUB TEAM

    • Donald Hillebrand, MD, Medical Director, UnityPoint Health – Center for Liver Disease
    • Steven Donnelly, PharmD, Community A Walgreens Specialty Pharmacy
    • Mark Hillenbrand, LISW, RCSW, Authentic Freedom Counseling Center
    • Megan Srinivas, MD, Infectious Disease, Community Health Centers of Fort Dodge
    • Malissa S. Sprenger, MS, IAADC, Coordinator, Turning Point Treatment Center

    ECHO Coordinators

    • Julie Baker, Director of Preventive Services, Iowa Primary Care Association
    • Chelsea Miller, Administrative Assistant, Iowa Primary Care Association

    Accreditation Statements

    • MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live, online activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
    • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
    • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.5 continuing education contact hour(s). No partial credit awarded.
    • Other Healthcare Professionals: This live activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.

    EDUCATIONAL GRANTS

    No commercial interest company provided financial support for this continuing education activity.

    DISCLOSURES

    Relevant to the content of this educational activity, the following individuals have no conflicts of interest with commercial interest companies to disclose.

    • Julie Baker, MPA, CHCEF, Activity Director and Planning Committee Member
    • Steven Donnelly, PharmD, Planning Committee Member
    • Faith Gachii, Coordinator
    • Chelsea Miller, Coordinator and Planning Committee Member
    • Malissa S. Sprenger, MS, IAADC, Planning Committee Member
    • Liz Sweet, Speaker

    Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.

    • Donald Hillebrand, MD, Speaker for AbbVie, Gilead, Merck, BMS, and Salix, Planning Committee Member
    • Mark Hillenbrand, LISW, RCSW, Spouse is a full-time employee at Vida Health, Planning Committee Member
    • Megan Srinivas, MD, Consultant (Self), Planning Committee Member

    The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

    Disclaimer

    The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

    Available Credit

    • 1.50 AMA PRA Category 1 Credits
    • 1.50 AOA Category 2­A
    • 1.50 CE Contact Hour(s)
    • 1.50 IBON

    Price

    Cost:
    $0.00
    Please login or Create an Account to take this course.

    There is no cost to attend. Sessions are the third Tuesday of the month. 

    The HCV ECHO is a tele-mentoring program that uses videoconferencing technology (Zoom) to combine MAT didactic presentations with interactive and practical HCV case presentations from participants.

    To register, email ECHO@iowapca.org the following information: Name, title, credentials, organization name, and email address.